Arrowhead Research Tumbles 20% Following FDA News By: Benzinga via Benzinga January 12, 2015 at 09:13 AM EST Shares of Arrowhead Research Corp (NASDAQ: ARWR) fell more than 20 percent in Monday’s premarket following news that the U.S. ... Read More >>